Active Ingredient(s):Macimorelin Acetate FDA Approved: * December 20, 2017 Pharm Company: *AETERNA ZENTARIS Category:Diagnostic Aid
Macimorelin (INN) – or Macrilen (trade name) – is a drug that was developed by Æterna Zentaris for use in the diagnosis of adult growth hormone deficiency. Macimorelin acetate, the salt formulation, is a synthetic growth hormone secretagogue receptor agonist. It is a growth hormone secretagogue receptor (ghrelin receptor) agonist causing release of growth hormone from the pituitary gland.[6&am...
* May have multiple approval dates, manufacturers, or labelers.